Optimizing Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation: Insights from the ORCA Trial—A Retrospective Study on 10 Years of Practice
(1) Background: Citrate is preferred in continuous renal replacement therapy (CRRT) for critically ill patients because it prolongs filter life and reduces bleeding risks compared to unfractionated heparin (UFH). However, regional citrate anticoagulation (RCA) can lead to acid–base disturbances, cit...
Những tác giả chính: | Rita Jacobs, Walter Verbrugghe, Jason Bouziotis, Ingrid Baar, Karolien Dams, Annick De Weerdt, Philippe G. Jorens |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
MDPI AG
2024-10-01
|
Loạt: | Life |
Những chủ đề: | |
Truy cập trực tuyến: | https://www.mdpi.com/2075-1729/14/10/1304 |
Những quyển sách tương tự
-
Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Bằng: Rita Jacobs, et al.
Được phát hành: (2023-05-01) -
Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis
Bằng: Min-min Wang, et al.
Được phát hành: (2023-10-01) -
Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy
Bằng: Desheng Zhu, et al.
Được phát hành: (2024-06-01) -
Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
Bằng: Jing Jiao, et al.
Được phát hành: (2023-12-01) -
Anticoagulation strategies for pediatric continuous renal replacement therapy
Bằng: Aakash Chandran Chidambaram, et al.
Được phát hành: (2024-09-01)